Antonio Anzueto

67.0k total citations · 10 hit papers
297 papers, 34.8k citations indexed

About

Antonio Anzueto is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Antonio Anzueto has authored 297 papers receiving a total of 34.8k indexed citations (citations by other indexed papers that have themselves been cited), including 190 papers in Pulmonary and Respiratory Medicine, 131 papers in Epidemiology and 59 papers in Physiology. Recurrent topics in Antonio Anzueto's work include Chronic Obstructive Pulmonary Disease (COPD) Research (112 papers), Pneumonia and Respiratory Infections (100 papers) and Respiratory Support and Mechanisms (92 papers). Antonio Anzueto is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (112 papers), Pneumonia and Respiratory Infections (100 papers) and Respiratory Support and Mechanisms (92 papers). Antonio Anzueto collaborates with scholars based in United States, Spain and United Kingdom. Antonio Anzueto's co-authors include Peter J. Barnes, Suzanne S. Hurd, Roberto Rodríguez-Roisin, Fernando J. Martínez, Claus Vogelmeier, Jørgen Vestbo, Marcos I. Restrepo, Àlvar Agustí, Paul Jones and Don D. Sin and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Antonio Anzueto

286 papers receiving 33.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

2012 9.4k citations Àlvar Agustí, Claus Vogelmeier et al. profile →
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

2007 4.4k citations Antonio Anzueto, Michael S. Niederman et al. Clinical Infectious Diseases profile →
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

2007 3.9k citations Antonio Anzueto, Peter J. Barnes et al. profile →
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America

2019 2.0k citations Antonio Anzueto, Mark L. Metersky et al. profile →
Guidelines for the Management of Adults with Community-acquired Pneumonia

2001 1.6k citations Michael S. Niederman, Antonio Anzueto et al. profile →
The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material

2012 902 citations Niall D. Ferguson, Antonio Anzueto et al. profile →
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease

2020 463 citations David Halpin, Gerard J. Criner et al. profile →
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline

2017 452 citations Peter M.A. Calverley, Antonio Anzueto et al. European Respiratory Journal profile →
Aerosolized Surfactant in Adults with Sepsis-Induced Acute Respiratory Distress Syndrome

1996 414 citations Antonio Anzueto, Kalpalatha K. Guntupalli et al. New England Journal of Medicine profile →
Effect of Corticosteroids on Treatment Failure Among Hospitalized Patients With Severe Community-Acquired Pneumonia and High Inflammatory Response

2015 373 citations Antoní Torres, Oriol Sibila et al. JAMA profile →

Peers

Countries citing papers authored by Antonio Anzueto

Since Specialization

Citations

This map shows the geographic impact of Antonio Anzueto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Anzueto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Anzueto more than expected).

Fields of papers citing papers by Antonio Anzueto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Anzueto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Anzueto. The network helps show where Antonio Anzueto may publish in the future.

Co-authorship network of co-authors of Antonio Anzueto

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Anzueto. A scholar is included among the top collaborators of Antonio Anzueto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Anzueto. Antonio Anzueto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Decarbonising Respiratory Care: The Impact of a Low‐Carbon Salbutamol Pressurised Metered‐Dose Inhalers 2025 ·Allergy ·James F. King, Ashley Woodcock, Antonio Anzueto, Alex Wilkinson, Christer Janson, Richard W. Henderson, (unknown), Maximilian Plank	0
2	Ensifentrine in COPD patients taking long-acting bronchodilators: A pooled post-hoc analysis of the ENHANCE-1/2 studies 2025 ·Chronic Respiratory Disease ·Mark T. Dransfield, (unknown), Ravi Kalhan, Daniel Reyner, (unknown), Tara Rheault, Kathleen Rickard, Antonio Anzueto	5
3	Reduced Risk of Mortality for COPD Patients Associated with Initiation of Treatment with Single Inhaler Triple Therapy (Budesonide/Glycopyrrolate/Formoterol) Versus Multiple Inhaler Triple Therapy in the United States: The MAZI Study 2024 ·Michael Pollack, Eleni Rapsomaniki, Antonio Anzueto, Kirsty Rhodes, Nathaniel M. Hawkins, Claus Vogelmeier, Jonathan Marshall, Hana Müllerová	1
4	Air pollution and COPD: GOLD 2023 committee report 2023 ·European Respiratory Journal ·Don D. Sin, Dany Doiron, Àlvar Agustí, Antonio Anzueto, Peter J. Barnes, Bartolomé R. Celli, Gerard J. Criner, David Halpin, MeiLan K. Han, Fernando J. Martínez, María Montes de, Alberto Papi, Ian Pavord, Nicolás Roche, Dave Singh, Robert A. Stockley, (unknown), Jadwiga A. Wedzicha, Claus Vogelmeier, Jean Bourbeau	75
5	Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease 2022 ·International Journal of COPD ·Jill Ohar, Gary T. Ferguson, Donald A. Mahler, Michael Drummond, Rajiv Dhand, Roy A. Pleasants, Antonio Anzueto, David Halpin, David Price, (unknown), Haley Hoy, John Haughney, (unknown), Omar S. Usmani	20
6	Effectiveness of Beta-Lactam plus Doxycycline for Patients Hospitalized with Community-Acquired Pneumonia 2021 ·Clinical Infectious Diseases ·(unknown), Turab Mohammed, Mark L. Metersky, Antonio Anzueto, Carlos A. Álvarez, Eric M. Mortensen	10
7	Pneumonia in Patients with Chronic Obstructive Pulmonary Disease 2018 ·Tuberculosis & respiratory diseases ·Marcos I. Restrepo, Oriol Sibila, Antonio Anzueto	72
8	Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD 2018 ·International Journal of COPD ·Peter M.A. Calverley, Antonio Anzueto, Daniel Dusser, Achim Mueller, Norbert Metzdorf, Robert A. Wise	16
9	Determinants of exacerbation risk in patients with COPD in the TIOSPIR study 2017 ·International Journal of COPD ·Peter M.A. Calverley, Kay Tetzlaff, Daniel Dusser, Robert A. Wise, Achim Mueller, (unknown), Antonio Anzueto	35
10	Acute Kidney Injury in Mechanically Ventilated Patients 2017 ·Shock ·Raúl Lombardi, Nicolás Nín, Óscar Peñuelas, Alejandro Ferreiro, Fernando Ríos, María C. Marín, Konstantinos Raymondos, José A. Lorente, Younsuck Koh, Javier Hurtado, Marco González, Fekri Abroug, Manuel Jibaja, Yaseen M. Arabi, Rui P. Moreno, Dimitros Matamis, Antonio Anzueto, Martin Dres	24
11	Community-Acquired Pneumonia Requiring Hospitalization. 2015 ·New England Journal of Medicine ·Pedro J. Marcos, Marcos I. Restrepo, Antonio Anzueto	4
12	Effect of Corticosteroids on Treatment Failure Among Hospitalized Patients With Severe Community-Acquired Pneumonia and High Inflammatory Response breakdown → 2015 ·JAMA ·Antoní Torres, Oriol Sibila, Miquel Ferrer, Eva Polverino, Rosario Menéndez, Josep Mensa, Albert Gabarrús, Jacobo Sellarés, Marcos I. Restrepo, Antonio Anzueto, Michael S. Niederman, Carles Agustı́	373
13	Safety and efficacy of tiotropium in patients switching from HandiHaler to Respimat in the TIOSPIR trial 2015 ·BMJ Open ·Ronald Dahl, Peter M.A. Calverley, Antonio Anzueto, Norbert Metzdorf, (unknown), Achim Mueller, Robert A. Wise, Daniel Dusser	8
14	Association of outpatient statin, ARB, and ACE inhibitor use on clinical outcomes for elderly subjects hospitalized with severe sepsis 2013 ·European Respiratory Journal ·Eric M. Mortensen, Mary Jo Pugh, John E. Cornell, Antonio Anzueto	2
15	Management and outcome of mechanically ventilated neurologic patients* 2011 ·Critical Care Medicine ·Paolo Pelosi, Niall D. Ferguson, Fernando Frutos–Vivar, Antonio Anzueto, Christian Putensen, Konstantinos Raymondos, Carlos Apezteguía, Pablo Desmery, Javier Hurtado, Fekri Abroug, José Elizalde, Vinko Tomicić, Nahit Çakar, Marco González, Yaseen M. Arabi, Rui P. Moreno, Martin Dres	162
16	Activity of a silver-coated endotracheal tube in preclinical models of ventilator-associated pneumonia and a study after extubation* 2010 ·Critical Care Medicine ·Jordi Rello, Bekele Afessa, Antonio Anzueto, Alejandro C. Arroliga, Merle S. Olson, Marcos I. Restrepo, (unknown), (unknown), Marin H. Kollef	35
17	EARLY AND SMALL CHANGES IN SERUM CREATININE CONCENTRATIONS ARE ASSOCIATED WITH MORTALITY IN MECHANICALLY VENTILATED PATIENTS 2010 ·Shock ·Nicolás Nín, Raúl Lombardi, Fernando Frutos–Vivar, (unknown), José A. Lorente, Niall D. Ferguson, Javier Hurtado, Carlos Apezteguía, Laurent Brochard, Frédérique Schortgen, Konstantinos Raymondos, Vinko Tomicić, Luis Soto, Marco González, Peter Nightingale, Fekri Abroug, Paolo Pelosi, Yaseen M. Arabi, Rui P. Moreno, Antonio Anzueto	28
18	Therapeutic strategies in acute exacerbations in COPD 2009 ·Mario Cazzola, Sanjay Sethi, Francesco Blasi, Antonio Anzueto	1
19	Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-l-arginine hydrochloride (546C88) in patients with septic shock: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002)* 2004 ·Critical Care Medicine ·David I. Watson, Robert F. Grover, Antonio Anzueto, José A. Lorente, Mark Smithies, Rinaldo Bellomo, Kalpalatha K. Guntupalli, Steven H. Grossman, Jill Donaldson, (unknown)	94
20	Acute exacerbations of chronic bronchitis: Fluoroquinolone clinical trial review 1999 ·Antonio Anzueto	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact